{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:18:58Z","timestamp":1768889938547,"version":"3.49.0"},"reference-count":57,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1979,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,4]]},"DOI":"10.1111\/j.1365-2885.2009.01122.x","type":"journal-article","created":{"date-parts":[[2009,8,14]],"date-time":"2009-08-14T11:18:26Z","timestamp":1250248706000},"page":"109-117","source":"Crossref","is-referenced-by-count":21,"title":["Aldosterone receptor antagonists - how cardiovascular actions may explain their beneficial effects in heart failure"],"prefix":"10.1111","volume":"33","author":[{"given":"P.","family":"OVAERT","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"ELLIOTT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"BERNAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"GUILLOT","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"BARDON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","reference":[{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/01.RES.88.3.298","article-title":"Canine ventricular myocytes possess a renin-angiotensin system that is upregulated with heart failure","volume":"88","author":"Barlucchi","year":"2001","journal-title":"Circulation Research"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB2","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0002-9149(99)80353-1","article-title":"Effects of adding spironolactone to an ACE inhibitor in congestive heart failure secondary to coronary heart disease","volume":"76","author":"Barr","year":"1995","journal-title":"The American Journal of Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1053\/tvjl.2001.0616","article-title":"Review. Canine idiopathic dilated cardiomyopathy. Part II: pathophysiology and therapy","volume":"162","author":"Borgarelli","year":"2001","journal-title":"The Veterinary Journal"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB4","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/01.RES.67.6.1355","article-title":"Remodeling of the rat right and left ventricles in experimental hypertension","volume":"67","author":"Brilla","year":"1990","journal-title":"Circulation Research"},{"issue":"Suppl. O","key":"10.1111\/j.1365-2885.2009.01122.x-BIB5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/eurheartj\/16.suppl_O.107","article-title":"The renin-angiotensin-aldosterone system and myocardial collagen matrix remodeling in congestive heart failure","volume":"16","author":"Brilla","year":"1995","journal-title":"European Heart Journal"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00210-006-0107-9","article-title":"Why are mineralocorticoid receptor antagonists cardioprotective?","volume":"374","author":"Chai","year":"2006","journal-title":"Naunyn-Schmiedeberg\u2019s Archives of Pharmacology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s10741-005-2350-4","article-title":"Autonomic effects of spironolactone and MR blockers in heart failure","volume":"10","author":"Davies","year":"2005","journal-title":"Heart Failure Reviews"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI119529","article-title":"Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces","volume":"100","author":"Dell\u2019italia","year":"1997","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB9","volume-title":"Prilactone\u00ae","author":"EMEA - European Medicines Agency - Veterinary Medicines","year":"2007"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB10","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.carpath.2006.04.003","article-title":"Arteriosclerotic changes in the myocardium, lung, and kidney in dogs with chronic congestive heart failure and myxomatous mitral valve disease","volume":"15","author":"Falk","year":"2006","journal-title":"Cardiovascular Pathology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB11","unstructured":"Falk, T. , J\u00f6nsson, L. , Olsen, L.H. , Tarnow, I. & Pedersen, H.D. . (2007) Correlation of cardiac pathology and clinical findings in dogs with naturally occurring congestive heart failure (Abstract). Proceedings of the 17th Annual ACVIM Congress, September (Abstract 23), Budapest, Hungary. Available at: www.emea.europa.eu (accessed on 5 August 2009)."},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/01.CIR.101.6.594","article-title":"Spironolactone increases nitric oxide bioactivity, improves endothelial vasodilator dysfunction, and suppresses vascular angiotensin I\/angiotensin II conversion in patients with chronic heart failure","volume":"101","author":"Farquharson","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jvc.2006.11.001","article-title":"Estimation of 24-h aldosterone secretion in the dog using the urine aldosterone creatinine ratio","volume":"9","author":"Gardner","year":"2007","journal-title":"Journal of Veterinary Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB14","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.2460\/ajvr.1996.57.11.1645","article-title":"Effects of long-term treatment with enalapril or hydralazine on the renin-angiotensin-aldosterone system and fluid balance in dogs with naturally acquired mitral valve regurgitation","volume":"57","author":"H\u00e4ggstr\u00f6m","year":"1996","journal-title":"American Journal of Veterinary Research"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB15","doi-asserted-by":"crossref","first-page":"24316","DOI":"10.1016\/S0021-9258(19)51084-5","article-title":"Vascular aldosterone biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells","volume":"269","author":"Hatakeyama","year":"1994","journal-title":"Journal of Biological Chemistry"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB16","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.2460\/ajvr.68.10.1058","article-title":"Effects of oral administration of furosemide and torasemide in healthy dogs","volume":"68","author":"Hori","year":"2007","journal-title":"American Journal of Veterinary Research"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB17","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cardiores.2005.10.020","article-title":"Cardiac mast cell regulation of matrix metalloproteinase-related ventricular remodeling in chronic pressure or volume overload","volume":"69","author":"Janicki","year":"2006","journal-title":"Cardiovascular Research"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jvc.2007.10.002","article-title":"Effect of spironolactone on diuresis and urine sodium and potassium excretion in healthy dogs","volume":"9","author":"Jeunesse","year":"2007","journal-title":"Journal of Veterinary Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB19","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/01.CIR.0000085658.98621.49","article-title":"Ventricular remodeling after infarction and the extracellular collagen matrix: when is enough enough?","volume":"108","author":"Jugdutt","year":"2003","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ncpcardio0914","article-title":"Drug insight: aldosterone-receptor antagonists in heart failure - the journey continues","volume":"4","author":"Kalidindi","year":"2007","journal-title":"Nature Clinical Practice Cardiovascular Medicine"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB21","first-page":"33","article-title":"Myocardial renin-angiotensin-aldosterone system and extracellular matrix remodeling","volume":"7","author":"Lijnen","year":"2003","journal-title":"Current Topics in Pharmacology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB22","first-page":"41","article-title":"Identification and role of aldosterone receptors in the cardiovascular system","volume":"61","author":"Lombes","year":"2000","journal-title":"Annales d\u2019Endocrinologie"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovascular Research"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1007\/BF03347366","article-title":"Aldosterone receptor antagonists: biology and novel therapeutical applications","volume":"26","author":"Magni","year":"2003","journal-title":"Journal of Endocrinological Investigation"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB25","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1046\/j.1440-1681.2003.03906.x","article-title":"Spironolactone prevents cardiac collagen proliferation after myocardial infarction in rats","volume":"30","author":"Mill","year":"2003","journal-title":"Clinical and Experimental Pharmacology and Physiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB26","first-page":"692","volume-title":"Textbook of Veterinary Internal Medicine","author":"de Morais","year":"2000"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB27","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.yjmcc.2005.05.015","article-title":"Spironolactone improves carotid artery fibrosis and distensibility in rat post-ischaemic heart failure","volume":"39","author":"Nehme","year":"2005","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11906-007-0009-3","article-title":"Mineralocorticoid receptor antagonists","volume":"9","author":"Parthasarathy","year":"2007","journal-title":"Current Hypertension Reports"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/j.1939-1676.2003.tb02431.x","article-title":"Decreased plasma concentration of nitric oxide metabolites in dogs with untreated mitral regurgitation","volume":"17","author":"Pedersen","year":"2003","journal-title":"Journal of Veterinary Internal Medicine"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB30","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1748-5827.2008.00654.x","article-title":"The Vasovagal Tonus Index as a prognostic indicator in dogs with dilated cardiomyopathy","volume":"49","author":"Pereira","year":"2008","journal-title":"Journal of Small Animal Practice"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB31","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure randomized aldactone evaluation study investigators","volume":"341","author":"Pitt","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB32","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0002-9149(96)00465-1","article-title":"Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive heart failure (the randomized aldactone evaluation study [RALES])","volume":"78","author":"RALES Investigators","year":"1996","journal-title":"The American Journal of Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB33","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB34","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2165\/00003495-200262050-00001","article-title":"Rationale for the use of aldosterone antagonists in congestive heart failure","volume":"62","author":"Rocha","year":"2002","journal-title":"Drugs"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB35","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB36","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/S0735-1097(02)02382-3","article-title":"Beneficial neurohormonal profile of spironolactone in severe congestive heart failure: results from the RALES neurohormonal substudy","volume":"40","author":"Rousseau","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB37","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/cs1020381","article-title":"Aldosterone synthase (CYP11B2) expression and myocardial fibrosis in the failing human heart","volume":"102","author":"Satoh","year":"2002","journal-title":"Clinical Science"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB38","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1097\/00060793-199906000-00006","article-title":"The cardiac endocrine aldosterone system","volume":"6","author":"Silvestre","year":"1999","journal-title":"Current Opinion in Endocrinology Diabetes and Obesity"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB39","first-page":"216","volume-title":"Textbook of Canine and Feline Cardiology. Principles and Clinical Practice","author":"Sisson","year":"1999"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB40","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S0022-2828(03)00013-0","article-title":"Cardiac mast cell- and chymase-mediated matrix metalloproteinase activity and left ventricular remodeling in mitral regurgitation in the dog","volume":"35","author":"Stewart","year":"2003","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB41","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00045415-200203000-00008","article-title":"Aldosterone as a mediator in cardiovascular injury","volume":"10","author":"Stier","year":"2002","journal-title":"Cardiology in Review"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1365-2125.1999.00954.x","article-title":"Why does spironolactone improve mortality over and above an ACE inhibitor in chronic heart failure?","volume":"47","author":"Struthers","year":"1999","journal-title":"British Journal of Clinical Pharmacology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB43","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.ejheart.2004.04.013","article-title":"The clinical implications of aldosterone escape in congestive heart failure","volume":"6","author":"Struthers","year":"2004","journal-title":"European Journal of Heart Failure"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB44","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart role of oxidative stress","volume":"161","author":"Sun","year":"2002","journal-title":"American Journal of Pathology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB45","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/01.CIR.0000039104.56479.42","article-title":"Effects of long-term monotherapy with eplerenone, a novel aldosterone blocker, on progression of left ventricular dysfunction and remodeling in dogs with heart failure","volume":"106","author":"Suzuki","year":"2002","journal-title":"Circulation"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB46","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.ijcard.2004.05.004","article-title":"Fiftieth anniversary of aldosterone: from discovery to cardiovascular therapy","volume":"96","author":"Tan","year":"2004","journal-title":"International Journal of Cardiology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB47","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jvc.2007.08.002","article-title":"Influence of combined angiotensin-converting enzyme inhibitors and spironolactone on serum K+, Mg2+, Na+ concentrations in small dogs with degenerative mitral valve disease","volume":"9","author":"Thomason","year":"2007","journal-title":"Journal of Veterinary Cardiolology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB48","doi-asserted-by":"crossref","first-page":"961","DOI":"10.2460\/ajvr.2001.62.961","article-title":"Effects of dilated cardiomyopathy on the renin-angiotensin-aldosterone system, atrial natriuretic peptide activity, and thyroid hormone concentrations in dogs","volume":"62","author":"Tidholm","year":"2001","journal-title":"American Journal of Veterinary Research"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB49","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1292\/jvms.65.1057","article-title":"The effects of the loop diuretics furosemide and torasemide on diuresis in dogs and cats","volume":"65","author":"Uechi","year":"2003","journal-title":"Journal of Veterinary Medical Science"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB50","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1161\/01.HYP.0000034738.79310.06","article-title":"Spironolactone improves angiotensin-induced vascular changes and oxidative stress","volume":"40","author":"Virdis","year":"2002","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB51","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1161\/01.HYP.24.5.571","article-title":"Chronic administration of aldosterone depresses baroreceptor reflex function in the dog","volume":"24","author":"Wang","year":"1994","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1161\/01.HYP.19.3.270","article-title":"Aldosterone reduces baroreceptor discharge in the dog","volume":"19","author":"Wang","year":"1992","journal-title":"Hypertension"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB53","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1056\/NEJMra000050","article-title":"Aldosterone in congestive heart failure","volume":"345","author":"Weber","year":"2001","journal-title":"The New England Journal of Medicine"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB54","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1677\/joe.0.1650533","article-title":"Aldosterone mediates angiotensin II-stimulated rat vascular smooth muscle cell proliferation","volume":"165","author":"Xiao","year":"2000","journal-title":"Journal of Endocrinology"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB55","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S1001-9294(09)60008-0","article-title":"Effects of spironolactone on electrical and structural remodeling of atrium in congestive heart failure dogs","volume":"121","author":"Yang","year":"2008","journal-title":"Chinese Medical Journal"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB56","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1042\/cs0950687","article-title":"Aldosterone blunts the baroreflex response in man","volume":"95","author":"Yee","year":"1998","journal-title":"Clinical Science"},{"key":"10.1111\/j.1365-2885.2009.01122.x-BIB57","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1161\/01.CIR.102.22.2700","article-title":"Limitation of excessive extracellular matrix turnover may contribute to survival benefit of spironolactone therapy in patients with congestive heart failure: insights from the randomized aldactone evaluation study (RALES) RALES investigators","volume":"102","author":"Zannad","year":"2000","journal-title":"Circulation"}],"container-title":["Journal of Veterinary Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2885.2009.01122.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2885.2009.01122.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T21:58:45Z","timestamp":1710539925000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-2885.2009.01122.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,4]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2885.2009.01122.x","relation":{},"ISSN":["0140-7783","1365-2885"],"issn-type":[{"value":"0140-7783","type":"print"},{"value":"1365-2885","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4]]}}}